Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis
NCT01214564
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Seborrheic Keratosis
Interventions
DRUG:
PEP005 (ingenol mebutate) Gel
Sponsor
Peplin